BlackRock’s Concord Medical Services CCM Stock Holding History

BlackRock’s Portfolio CCM Stock Details CCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14	Closed	-$157	–	5292
2023 Q4	$157	Hold	14	–	–	﹤0.01%	5324
2023 Q3	$183	Hold	14	–	–	﹤0.01%	5385
2023 Q2	$197	Hold	14	–	–	﹤0.01%	5446
2023 Q1	$178	Hold	14	–	–	﹤0.01%	5522
2022 Q4	$235	Hold	14	–	–	﹤0.01%	5697
2022 Q3	$0	Hold	14	–	–	﹤0.01%	5806
2022 Q2	$0	Hold	14	–	–	﹤0.01%	5861
2022 Q1	$0	Hold	14	–	–	﹤0.01%	5820
2021 Q4	$0	Hold	14	–	–	﹤0.01%	5790
2021 Q3	$0	Sell	14 -37	-73%	-$1.03K	﹤0.01%	5616
2021 Q2	$1K	Hold	51	–	–	﹤0.01%	5447
2021 Q1	$2K	Buy	+51	New	+$1.87K	﹤0.01%	5197

Other funds holding CCM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock's CCM Position: Q1 2024 in Review

BlackRock sold out of Concord Medical Services (CCM) in Q1 2024, closing a stake of 14 shares — an estimated $157 sold.

BlackRock first reported a position in CCM in Q1 2021 and held it in 12 quarters. The position peaked at $2K in Q1 2021. 3 funds tracked by Wall St. Rank hold CCM as of Q1 2024.

BlackRock reported no remaining Concord Medical Services position as of Q1 2024 after selling out during the quarter.
BlackRock sold 14 Concord Medical Services shares in Q1 2024, an estimated $157.
BlackRock first reported a position in Concord Medical Services in Q1 2021 and held it in 12 quarters.
BlackRock's Concord Medical Services position peaked at $2K in Q1 2021.
3 funds tracked by Wall St. Rank held Concord Medical Services as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.